CLBT Earnings Prediction
The chart below shows how CLBT performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CLBT sees a -4.43% change in stock price 10 days leading up to the earnings, and a -1.05% change 10 days following the report. On the earnings day itself, the stock moves by +2.63%. This data can give you a slight idea of what to expect for the next quarter's release.
CLBT Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
106.86M
26.94%
11.64%
Gross Margin
85.55%
1.00%
3.06%
Operating Margin
18.40%
14.50%
41.00%
Net Margin
-193.80%
-2610.36%
678.94%
EPS
-0.99
-3400.00%
725.00%
No Data Available
CLBT Earnings Analysis
Cellebrite DI Ltd. Class A Ordinary Shares Corporation (CLBT.O) Earnings Conference Call
Positive
Historic Revenue Milestone: 1. Record Revenue Achievement: Cellebrite reported a historic quarterly revenue of $106.8 million, marking a 27% increase year-over-year, driven by a 27% rise in subscription revenue.
ARR Growth Surge: 2. Significant ARR Growth: The company's Annual Recurring Revenue (ARR) grew by 26% year-over-year, reaching $371 million, with strong contributions from the Insights suite and a gross retention rate of approximately 91%.
Profitability Improvement: 3. Strong Profitability Metrics: Cellebrite achieved an adjusted EBITDA of $31.3 million, representing a 29% margin, an increase from 25% in the previous year, showcasing effective cost management alongside revenue growth.
Strong Cash Reserves: 4. Robust Cash Position: The company ended the quarter with $413.6 million in cash and cash equivalents, reflecting a $130.4 million increase from the same quarter last year, bolstered by strong operational cash flow.
Cloud Product Growth: 5. Cloud Product Success: The Guardian product suite saw over 100% growth in the past year, indicating strong demand for SaaS-based solutions that enhance digital evidence management and collaboration.
Negative
Operating Expenses Surge: 1. Increased Operating Expenses: Q3 operating costs rose to $62.5 million, a 19% year-over-year increase, primarily due to higher personnel costs and one-time project expenses in R&D.
Employee Growth Surge: 2. High Employee Growth: The company ended Q3 with 1,109 employees, marking a 12% increase from the same quarter last year, indicating potential rising costs without immediate revenue assurance.
Limited Impact of Acquisition: 3. Minimal Contribution from CyTech Acquisition: The CyTech acquisition contributed slightly below $0.5 million to total revenue in Q3, highlighting a lack of significant impact from this strategic move.
Share Count Dilution Impact: 4. Diluted Share Count Increase: The diluted weighted average share outstanding increased by 7% from Q2 levels due to warrant exercises, which could dilute existing shareholder value.
Leadership Transition Concerns: 5. CEO Transition Uncertainty: The announcement of Yossi Carmil's departure as CEO raises concerns about leadership stability and potential impacts on company strategy and performance during the transition period.
CLBT FAQs
How does CLBT typically perform around its earnings report dates?
Is Cellebrite DI Ltd. (CLBT) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
CLBT Earning Call Sentiment
Cellebrite DI Ltd. (CLBT) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
CLBT.O
0.26%Positive
Cellebrite's earnings call highlights strong financial performance with a 27% revenue increase and a raised revenue outlook. Despite competitive pressures and leadership transition risks, the company maintains high gross margins and a robust cash position. The Q&A indicates a positive sentiment towards growth and AI integration. The strategic partnership with Relativity and raised guidance further support a positive outlook. Given the market cap, the stock price is likely to react positively within the 2% to 8% range over the next two weeks.
